Category:
Fine Chemicals
CAS NO:
1053618-42-0
Standard:
In-house Standards,
PT-112 (CAS 65997-80-4) is a novel anticancer agent, specifically a platinum-based DNA cross-linking compound designed for enhanced tumor penetration. Its core process involves the synthesis of a lipophilic prodrug to improve bioavailability compared to standard platinum therapies.
Strict adherence to clinical trial protocols is mandatory due to potential neurotoxicity and nephrotoxicity. Storage requires controlled temperature and humidity to maintain chemical stability.